Our top pick for
Beginners
Pluristem is a biotechnology business based in the US. Pluristem shares (PSTI) are listed on the NASDAQ and all prices are listed in US Dollars. Pluristem employs 153 staff and has a trailing 12-month revenue of around $234,000.
How to buy shares in Pluristem
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PSTI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Pluristem stock price (NASDAQ: PSTI)
Use our graph to track the performance of PSTI stocks over time.Pluristem shares at a glance
Information last updated 2022-10-02.
| Latest market close | $0.67 |
|---|---|
| 52-week range | $0.66 - $3.19 |
| 50-day moving average | $1.19 |
| 200-day moving average | $1.76 |
| Wall St. target price | $3.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.46 |
Buy Pluristem shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Pluristem stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Pluristem price performance over time
Historical closes compared with the close of $0.67 from 2022-09-26
| 1 week (2022-09-26) | 0.67 |
|---|---|
| 1 month (2022-09-02) | -24.73% |
| 3 months (2022-07-05) | -48.06% |
| 6 months (2022-04-05) | -69.27% |
| 1 year (2021-10-05) | -73.52% |
|---|---|
| 2 years (2020-10-05) | -93.60% |
| 3 years (2019-10-04) | 3.66 |
| 5 years (2017-10-04) | 1.5 |
Pluristem financials
| Revenue TTM | $234,000 |
|---|---|
| Gross profit TTM | $23,000 |
| Return on assets TTM | -37.35% |
| Return on equity TTM | -86.55% |
| Profit margin | 0% |
| Book value | $1.18 |
| Market capitalisation | $32.3 million |
TTM: trailing 12 months
Pluristem share dividends
We're not expecting Pluristem to pay a dividend over the next 12 months.
Have Pluristem's shares ever split?
Pluristem's shares were split on a 1:10 basis on 25 July 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Pluristem shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Pluristem shares which in turn could have impacted Pluristem's share price.
Pluristem share price volatility
Over the last 12 months, Pluristem's shares have ranged in value from as little as $0.6556 up to $3.19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pluristem's is 1.9127. This would suggest that Pluristem's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Pluristem overview
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA's Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions.
Frequently asked questions
What percentage of Pluristem is owned by insiders or institutions?Currently 7.281% of Pluristem shares are held by insiders and 12.805% by institutions. How many people work for Pluristem?
Latest data suggests 153 work at Pluristem. When does the fiscal year end for Pluristem?
Pluristem's fiscal year ends in June. Where is Pluristem based?
Pluristem's address is: Building No. 5, Haifa, Israel, 3508409 What is Pluristem's ISIN number?
Pluristem's international securities identification number is: US72940R3003 What is Pluristem's CUSIP number?
Pluristem's Committee on Uniform Securities Identification Procedures number is: 72940P106
More guides on Finder
-
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
-
Manganese stocks
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
-
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
-
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
-
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
-
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
-
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
-
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
-
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert